Feeds › Ownership stakes (13D / 13G)
Ownership stakes (13D / 13G)
Investors who own more than 5% of a company, from activists (13D) to passive holders (13G).
About this data
- What it is
- An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
- Who files it
- The investor, within days of crossing 5%, and again whenever the stake changes materially.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- 13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Filings per day, last 30 days
13D (activist) 13G (passive)
Latest ownership filings
Showing: ticker ADAG
| Filed | ScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders. | Company | Investor | Shares | % of shares | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 2026 | SCHEDULE 13G/A (amended) | ADAG Adagene Inc. | WuXi AppTec Co., Ltd. | 2.89M | 3.5% | SCHEDULE 13G/A ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A (amended) | ADAG Adagene Inc. | WuXi PharmaTech Healthcare Fund I L.P. | 2.89M | 3.5% | SCHEDULE 13G/A ↗ |
| Jun 8, 2026 | SCHEDULE 13D/A (amended) | ADAG Adagene Inc. | HAN 2020 Irrevocable Trust | 9.39M | 11.2% | SCHEDULE 13D/A ↗ |
| Jun 8, 2026 | SCHEDULE 13D/A (amended) | ADAG Adagene Inc. | Peter Luo | 6.24M | 7.1% | SCHEDULE 13D/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | ADAG Adagene Inc. | WuXi AppTec Co., Ltd. | 3.49M | 5.9% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | ADAG Adagene Inc. | WuXi PharmaTech Healthcare Fund I L.P. | 3.49M | 5.9% | SCHEDULE 13G/A ↗ |
| May 7, 2026 | SCHEDULE 13G | ADAG Adagene Inc. | Janus Henderson Group PLC | 6.67M | 10.1% | SCHEDULE 13G ↗ |
| Mar 18, 2026 | SCHEDULE 13G | ADAG Adagene Inc. | Chernett Jorey | 2.39M | 5.1% | SCHEDULE 13G ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | ADAG Adagene Inc. | General Atlantic Singapore AI Pte. Ltd. | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | ADAG Adagene Inc. | General Atlantic (Lux) S.a r.l. | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | ADAG Adagene Inc. | General Atlantic GenPar (Lux) SCSp | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | ADAG Adagene Inc. | General Atlantic Partners (Lux) SCSp | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | ADAG Adagene Inc. | GAP Coinvestments CDA, L.P. | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | ADAG Adagene Inc. | GAP Coinvestments V, LLC | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | ADAG Adagene Inc. | GAP Coinvestments IV, LLC | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | ADAG Adagene Inc. | GAP Coinvestments III, LLC | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | ADAG Adagene Inc. | General Atlantic, L.P. | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | ADAG Adagene Inc. | GAP (Bermuda) L.P. | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | ADAG Adagene Inc. | General Atlantic GenPar (Bermuda), L.P. | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | ADAG Adagene Inc. | General Atlantic Partners (Bermuda) EU, L.P. | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | ADAG Adagene Inc. | General Atlantic Partners (Bermuda) IV, L.P. | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | ADAG Adagene Inc. | General Atlantic Singapore Interholdco Ltd. | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | ADAG Adagene Inc. | General Atlantic Singapore Fund Pte. Ltd. | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Jan 29, 2026 | SCHEDULE 13G/A (amended) | ADAG Adagene Inc. | VCS Master Holdings GP | 185,701 | 1.0% | SCHEDULE 13G/A ↗ |
| Jan 29, 2026 | SCHEDULE 13G/A (amended) | ADAG Adagene Inc. | The Vincent C. Smith, Jr. 2025 Annuity Trust | 3.61M | 6.1% | SCHEDULE 13G/A ↗ |
| Jan 29, 2026 | SCHEDULE 13G/A (amended) | ADAG Adagene Inc. | Vincent C. Smith | 5.10M | 8.7% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | ADAG Adagene Inc. | WuXi AppTec Co., Ltd. | 4.12M | 7.0% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | ADAG Adagene Inc. | WuXi PharmaTech Healthcare Fund I L.P. | 4.12M | 7.0% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | ADAG Adagene Inc. | James Huang | 2.25M | 3.8% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | ADAG Adagene Inc. | Panacea Innovation Limited | 2.25M | 3.8% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | ADAG Adagene Inc. | Panacea Venture Healthcare Fund II GP Company, Ltd. | 2.25M | 3.8% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | ADAG Adagene Inc. | Panacea Venture Healthcare Fund II, L.P. | 2.25M | 3.8% | SCHEDULE 13G/A ↗ |
| Jul 2, 2025 | SCHEDULE 13G/A (amended) | ADAG Adagene Inc. | Abigail P. Johnson | 473,949 | 0.9% | SCHEDULE 13G/A ↗ |
| Jul 2, 2025 | SCHEDULE 13G/A (amended) | ADAG Adagene Inc. | FMR LLC | 473,949 | 0.9% | SCHEDULE 13G/A ↗ |
| May 15, 2025 | SCHEDULE 13G/A (amended) | ADAG Adagene Inc. | WuXi AppTec Co., Ltd. | 4.98M | 8.5% | SCHEDULE 13G/A ↗ |
| May 15, 2025 | SCHEDULE 13G/A (amended) | ADAG Adagene Inc. | WuXi PharmaTech Healthcare Fund I L.P. | 4.98M | 8.5% | SCHEDULE 13G/A ↗ |
| May 12, 2025 | SCHEDULE 13G/A (amended) | ADAG Adagene Inc. | Pandanus Associates, Inc. | 936,810 | 1.8% | SCHEDULE 13G/A ↗ |
| May 12, 2025 | SCHEDULE 13G/A (amended) | ADAG Adagene Inc. | Pandanus Partners, L.P. | 936,810 | 1.8% | SCHEDULE 13G/A ↗ |
| May 12, 2025 | SCHEDULE 13G/A (amended) | ADAG Adagene Inc. | FIL Limited | 936,810 | 1.8% | SCHEDULE 13G/A ↗ |
| Feb 19, 2025 | SCHEDULE 13D/A (amended) | ADAG Adagene Inc. | HAN 2020 Irrevocable Trust | 9.18M | 15.6% | SCHEDULE 13D/A ↗ |
| Feb 19, 2025 | SCHEDULE 13D/A (amended) | ADAG Adagene Inc. | Peter Luo | 3.68M | 6.1% | SCHEDULE 13D/A ↗ |
| Feb 14, 2025 | SCHEDULE 13G/A (amended) | ADAG Adagene Inc. | James Huang | 3.04M | 5.5% | SCHEDULE 13G/A ↗ |
| Feb 14, 2025 | SCHEDULE 13G/A (amended) | ADAG Adagene Inc. | Panacea Innovation Limited | 3.04M | 5.5% | SCHEDULE 13G/A ↗ |
| Feb 14, 2025 | SCHEDULE 13G/A (amended) | ADAG Adagene Inc. | Panacea Venture Healthcare Fund II GP Company, Ltd. | 3.04M | 5.5% | SCHEDULE 13G/A ↗ |
| Feb 14, 2025 | SCHEDULE 13G/A (amended) | ADAG Adagene Inc. | Panacea Venture Healthcare Fund II, L.P. | 3.04M | 5.5% | SCHEDULE 13G/A ↗ |
| Feb 12, 2025 | SCHEDULE 13G/A (amended) | ADAG Adagene Inc. | Pandanus Associates, Inc. | 4.09M | 7.8% | SCHEDULE 13G/A ↗ |
| Feb 12, 2025 | SCHEDULE 13G/A (amended) | ADAG Adagene Inc. | Pandanus Partners, L.P. | 4.09M | 7.8% | SCHEDULE 13G/A ↗ |
| Feb 12, 2025 | SCHEDULE 13G/A (amended) | ADAG Adagene Inc. | FIL Limited | 4.09M | 7.8% | SCHEDULE 13G/A ↗ |
| Feb 4, 2025 | SCHEDULE 13G | ADAG Adagene Inc. | VCS Master Holdings GP | 185,701 | 1.0% | SCHEDULE 13G ↗ |
| Feb 4, 2025 | SCHEDULE 13G | ADAG Adagene Inc. | Red Beard Holdings, LLC | 3.13M | 5.6% | SCHEDULE 13G ↗ |
Full history on every feed is part of Premium. Premium loads older rows, up to 10,000, and CSV downloads.
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:46 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances